Investigation and management of hypercalcaemia in children

Archives of Disease in Childhood

Volumn 97, Issue 6, 2012, Pages 533-538

  Davies, Justin Huw ^a   Shaw, Nicholas J ^b  

^a UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^b BIRMINGHAM CHILDREN S HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; CALCITRIOL; CALCIUM; CALCIUM SENSING RECEPTOR; CINACALCET; CLODRONIC ACID; FUROSEMIDE; IBANDRONIC ACID; INTERLEUKIN 1; INTERLEUKIN 6; MAGNESIUM; OSTEOCLAST DIFFERENTIATION FACTOR; PAMIDRONIC ACID; PARATHYROID HORMONE; PHOSPHOLIPASE C; PREDNISOLONE; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA;

ABDOMINAL PAIN; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ANOREXIA; BONE PAIN; CALCIUM ABSORPTION; CALCIUM BLOOD LEVEL; CHILDHOOD DISEASE; CHONDRODYSPLASIA; CLINICAL EVALUATION; CONSCIOUSNESS DISORDER; CONSTIPATION; DRUG DOSE REDUCTION; DYSGERMINOMA; ENZYME ACTIVITY; FAILURE TO THRIVE; FAT NECROSIS; FEEDBACK SYSTEM; HEMODIALYSIS; HEPATOBLASTOMA; HYDRATION; HYPERCALCEMIA; HYPERPARATHYROIDISM; HYPOCALCIURIA; IMMOBILIZATION; JANSEN METAPHYSEAL CHONDRODYSPLASIA; KIDNEY FAILURE; LETHARGY; LIGHTWOOD SYNDROME; LIVER SARCOMA; LYMPHOMA; MAGNESIUM BLOOD LEVEL; MEDULLOBLASTOMA; METABOLIC ALKALOSIS; MUSCLE HYPOTONIA; NEONATAL HYPERPARATHYROIDISM; NEONATAL SEVERE HYPERPARATHYROIDISM; PANCREATITIS; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROIDECTOMY; POLYDIPSIA; POLYURIA; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; RHABDOMYOSARCOMA; SECONDARY HYPERPARATHYROIDISM; VOMITING; WEIGHT REDUCTION; WILLIAMS BEUREN SYNDROME;

ADULT; CALCIUM; CHILD; HOMEOSTASIS; HUMANS; HYPERCALCEMIA; PARATHYROID HORMONE; VITAMIN D;

EID: 84861478473     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/archdischild-2011-301284     Document Type: Review

References (34)

1. Kollars J, Zarroug AE, van Heerden J, et al. Primary hyperparathyroidism in pediatric patients. Pediatrics 2005;115:974-80.
2. Venail F, Nicollas R, Morin D, et al. Solitary parathyroid adenoma: a rare cause of primary hyperparathyroidism in children. Laryngoscope 2007;117:946-9. (Pubitemid 46699377)
3. Mallet E. Primary hyperparathyroidism in neonates and childhood. The French experience (1984-2004). Horm Res 2008;69:180-8. (Pubitemid 351161047)
4. Benaderet AD, Burton AM, Clifton-Bligh R, et al. Primary hyperparathyroidism with low intact PTH levels in a 14-year-old girl. J Clin Endocrinol Metab 2011;96:2325-9.
5. Hsu SC, Levine MA. Primary hyperparathyroidism in children and adolescents: the Johns Hopkins Children's Center experience 1984-2001. J Bone Miner Res 2002;17(Suppl 2):N44-50. (Pubitemid 35222312)
6. Vanstone MB, Udelsman RD, Cheng DW, et al. Rapid correction of bone mass after parathyroidectomy in an adolescent with primary hyperparathyroidism. J Clin Endocrinol Metab 2011;96:E347-50.
7. Miyashiro K, Kunii I, Manna TD, et al. Severe hypercalcemia in a 9-year-old Brazilian girl due to a novel inactivating mutation of the calcium-sensing receptor. J Clin Endocrinol Metab 2004;89:5936-41. (Pubitemid 39628396)
8. Tõke J, Czirják G, Patócs A, et al. Neonatal severe hyperparathyroidism associated with a novel de novo heterozygous R551K inactivating mutation and a heterozygous A986S polymorphism of the calcium-sensing receptor gene. Clin Endocrinol (Oxf) 2007;67:385-92.
9. Reh CM, Hendy GN, Cole DE, et al. Neonatal hyperparathyroidism with a heterozygous calcium-sensing receptor (CASR) R185Q mutation: clinical benefit from cinacalcet. J Clin Endocrinol Metab 2011;96:E707-12.
10. Nissen PH, Christensen SE, Heickendorff L, et al. Molecular genetic analysis of the calcium sensing receptor gene in patients clinically suspected to have familial hypocalciuric hypercalcemia: phenotypic variation and mutation spectrum in a Danish population. J Clin Endocrinol Metab 2007;92:4373-9. (Pubitemid 350074759)
11. Lietman SA, Tenenbaum-Rakover Y, Jap TS, et al. A novel loss-of-function mutation, Gln459Arg, of the calcium-sensing receptor gene associated with apparent autosomal recessive inheritance of familial hypocalciuric hypercalcemia. J Clin Endocrinol Metab 2009;94:4372-9.
12. Christensen SE, Nissen PH, Vestergaard P, et al. Skeletal consequences of familial hypocalciuric hypercalcaemia vs. primary hyperparathyroidism. Clin Endocrinol (Oxf) 2009;71:798-807.
13. Pearce SH, Wooding C, Davies M, et al. Calcium-sensing receptor mutations in familial hypocalciuric hypercalcaemia with recurrent pancreatitis. Clin Endocrinol (Oxf) 1996;45:675-80. (Pubitemid 27032312)
14. Pallais JC, Kemp EH, Bergwitz C, et al. Autoimmune hypocalciuric hypercalcemia unresponsive to glucocorticoid therapy in a patient with blocking autoantibodies against the calcium-sensing receptor. J Clin Endocrinol Metab 2011;96:672-80.
15. McKay C, Furman WL. Hypercalcemia complicating childhood malignancies. Cancer 1993;72:256-60. (Pubitemid 23182082)
16. Stewart AF. Clinical practice. Hypercalcemia associated with cancer. N Engl J Med 2005;352:373-9.
17. Lakhdir F, Lawson D, Schatz DA. Fatal parathyroid hormone-related proteininduced humoral hypercalcemia of malignancy in a 3-month-old infant. Eur J Pediatr 1994;153:718-20. (Pubitemid 24300469)
18. Dharmaraj P, Ball S, Johnstone H, et al. Hypercalcaemia in relapsed medulloblastoma 8 years post-diagnosis; evidence to support PTHrP production by medulloblastoma cells. Horm Res 2006;66:268-72. (Pubitemid 44795909)
19. Hibi M, Masahito H, Hara F, et al. 1,25-dihydroxyvitamin D-mediated hypercalcemia in ovarian dysgerminoma. Pediatr Hematol Oncol 2008;25:73-8. (Pubitemid 351168920)
20. Niizuma H, Fujii K, Sato A, et al. PTHrP-independent hypercalcemia with increased proinflammatory cytokines and bone resorption in two children with CD19-negative precursor B acute lymphoblastic leukemia. Pediatr Blood Cancer 2007;49:990-3. (Pubitemid 350022459)
21. Shimonodan H, Nagayama J, Nagatoshi Y, et al. Acute lymphocytic leukemia in adolescence with multiple osteolytic lesions and hypercalcemia mediated by lymphoblast-producing parathyroid hormone-related peptide: a case report and review of the literature. Pediatr Blood Cancer 2005;45:333-9. (Pubitemid 41077168)
22. Cross SF, Dalla Pozza L, Munns CF. Hypercalcemia and osteoblastic lesions induced by 13-Cis-retinoic acid mimicking relapsed neuroblastoma. Pediatr Blood Cancer 2009;53:666-8.
23. Go T. Low-dose oral etidronate therapy for immobilization hypercalcaemia associated with Guillain-Barré syndrome. Acta Paediatr 2001;90:1202-4. (Pubitemid 32964501)
24. Pronicka E, Rowinska E, Kulczycka H, et al. Persistent hypercalciuria and elevated 25-hydroxyvitamin D3 in children with infantile hypercalcaemia. Pediatr Nephrol 1997;11:2-6. (Pubitemid 27049401)
25. Huang J, Coman D, McTaggart SJ, et al. Long-term follow-up of patients with idiopathic infantile hypercalcaemia. Pediatr Nephrol 2006;21:1676-80. (Pubitemid 44390832)
26. Udwin O, Yule W, Martin ND. Age at diagnosis and abilities in idiopathic hypercalcaemia. Arch Dis Child 1986;61:1164-7. (Pubitemid 17190349)
27. Schlingmann KP, Kaufmann M, Weber S, et al. Mutations in CYP24A1 and idiopathic infantile hypercalcemia. N Engl J Med 2011;365:410-21.
28. Pober BR. Williams-Beuren syndrome. N Engl J Med 2010;362:239-52.
29. Kitagawa H, Fujiki R, Yoshimura K, et al. The chromatin-remodeling complex WINAC targets a nuclear receptor to promoters and is impaired in Williams syndrome. Cell 2003;113:905-17. (Pubitemid 36792033)
30. Schipani E, Langman C, Hunzelman J, et al. A novel parathyroid hormone (PTH)/PTH-related peptide receptor mutation in Jansen's metaphyseal chondrodysplasia. J Clin Endocrinol Metab 1999;84:3052-7. (Pubitemid 30646922)
31. Farooque A, Moss C, Zehnder D, et al. Expression of 25-hydroxyvitamin D3-1alphahydroxylase in subcutaneous fat necrosis. Br J Dermatol 2009;160:423-5.
32. Alos N, Eugène D, Fillion M, et al. Pamidronate treatment for severe hypercalcemia in neonatal subcutaneous fat necrosis. Horm Res 2006;65:289-94. (Pubitemid 43876731)
33. Platt C, Inward C, McGraw M, et al. Middle-term use of Cinacalcet in paediatric dialysis patients. Pediatr Nephrol 2010;25:143-8.
34. Rus R, Haag C, Bumke-Vogt C, et al. Novel inactivating mutations of the calcium-sensing receptor: the calcimimetic NPS R-568 improves signal transduction of mutant receptors. J Clin Endocrinol Metab 2008;93:4797-803.